Exclusive

Publication

Byline

Location

Taiwan Manufacturing PMI Ticks Higher In May - S&P Global

India, June 1 -- The manufacturing sector in Taiwan continued to contract in May, albeit at a slower pace, the latest survey from S&P Global revealed on Monday with a manufacturing PMI score of 48.6. ... Read More


Indonesia Manufacturing PMI Improves In May - S&P Global

India, June 1 -- The manufacturing sector in Indonesia continued to contract in May, albeit at a slower pace, the latest survey from S&P Global revealed on Monday with a manufacturing PMI score of 47.... Read More


NIO May Vehicle Deliveries Up 13.1%

India, June 1 -- NIO Inc. (NIO), a Chinese multinational automobile manufacturer, Sunday reported that it delivered 23,231 vehicles in May 2025, up 13.1 percent year-over-year. The deliveries consist... Read More


Japan Capital Spending Data Due On Monday

India, June 1 -- Japan will on Monday release Q1 figures for capital spending, highlighting a modest day for Asia-Pacific economic activity. In the previous three months, capex was down 0.2 percent on... Read More


XPeng May Vehicle Delivers Surges

India, June 1 -- XPeng Inc. (XPEV) delivered 33,525 smart electric vehicles in May 2025. This was a huge increase of 230% compared to the same month last year. The company also continued its strong pe... Read More


Li Auto May Vehicle Deliveries Up 16.7%

India, June 1 -- Li Auto Inc. (LI) announced that it delivered 40,856 vehicles in May 2025, representing a year-over-year increase of 16.7%. In late May, Li Auto began to roll out OTA update version ... Read More


Pfizer Reveals Phase 3 Results For Vepdegestrant In Advanced Breast Cancer Treatment

India, May 31 -- Arvinas Inc. (ARVN) and Pfizer Inc. (PFE) announced detailed results from the Phase 3 VERITAC-2 clinical trial evaluating vepdegestrant monotherapy versus fulvestrant in adults with e... Read More


AZN And Daiichi Sankyo's ENHERTU Shows Significant Survival Benefit In Phase 3 Gastric Cancer Trial

India, May 31 -- AstraZeneca (AZN,AZN.L) and Daiichi Sankyo (DSKYF.PK) announced that positive results from the DESTINY-Gastric04 phase 3 trial showed ENHERTU (trastuzumab deruxtecan) demonstrated a s... Read More


Regeneron Unveils Detailed Phase 3 C-POST Trial Results For Libtayo In High-Risk CSCC Patients

India, May 31 -- Regeneron Pharmaceuticals Inc. (REGN) announced detailed analyses from the Phase 3 C-POST trial, which evaluated PD-1 inhibitor Libtayo (cemiplimab)in patients with high-risk cutaneou... Read More


Phase III Study Shows Genentech's Itovebi Combo Cuts Death Risk By 30% In Advanced Breast Cancer

India, May 31 -- Genentech, a member of the Roche Group (RHHBY), announced positive final results from the overall survival analysis of the Phase III INAVO120 study. These data showed Itovebi (inavoli... Read More